Skip to main content
Premium Trial:

Request an Annual Quote

DARPA Awards Genelabs $13.6 Million Biological Toxins Research Grant


REDWOOD CITY, Calif.--The Defense Advanced Research Projects Agency (DARPA) awarded Genelabs Technologies here a three-year $13.6 million research grant to apply patented technologies to the discovery of small molecule drugs to block pathogens that might be used as biological warfare weapons.

Genelabs' proprietary high-throughput assay system enables the discovery and characterization of molecules that bind to DNA via the screening of combinatorial chemistry libraries. Information derived from the system allows the rational design of compounds that function by binding to specific DNA sequences to regulate gene expression.

Sister technology enables discovery of molecules that bind to double-stranded RNA and has the potential to enable the construction of drugs targeted specifically to RNA viruses, another class of biological warfare agents.

"DARPA is investing in innovative technologies that have the potential to provide significant advances in developing broad countermeasures to biological agents," Program Director Shaun Jones stated.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.